Indeed, expressed CCL18 levels were significantly increased in BAL-derived cells from IPF patients compared to patients with other fibrotic diseases, such as sarcoidosis or hypersensitivity pneumonitis, and healthy controls [44]. This evidence concerns the gene CCL18 and idiopathic pulmonary fibrosis.